The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians
Open Access
- 12 March 2020
- journal article
- research article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 34 (11), 2574-2583
- https://doi.org/10.1111/jdv.16340
Abstract
Background In shared decision making (SDM) patients and physicians work together to choose the best treatment option for an individual patient. Atopic dermatitis (AD) and psoriasis are particularly suitable for SDM, considering that the best treatment option depends on a patient’s preferences and values (preference‐sensitive decisions). Currently it is unknown to what extent SDM is applied in treatment decisions for these diseases in The Netherlands. Objectives Primary, to assess the current extent of SDM in AD and psoriasis in the Netherlands amongst patients and dermatologists. Secondary, to assess the degree to which patients and physicians endorse SDM, to explore which characteristics are related to their preference to be involved in SDM and to identify which barriers and facilitators for SDM they perceive. Methods Two similar online surveys, one for patients with AD or psoriasis and one for (resident) dermatologists, were carried out. The surveys comprised validated questionnaires (Shared Decision Making Questionnaire (SDM‐Q; range 0‐100), Control Preference Scale) and study‐specific statements mainly regarding barriers and facilitators for SDM. Results The responses of 219 patients and 147 physicians were analysed. Dermatologists experienced significantly more SDM than patients (SDM‐Q 82 vs 55;p<0.01). Most patients and dermatologists prefer to share treatment decisions. Mainly facilitators for SDM were perceived, including the positive perception of patients and dermatologists regarding SDM. The perceived barriers included lack of continuity of care by the same physician and lack of time. Conclusion Despite the dermatologists’ optimistic perspective, patients experience a limited extent of SDM and physicians should be aware of this gap. Improvement of SDM in AD and psoriasis is needed. The positive attitude of patients and dermatologists towards the process and outcome of SDM are important facilitators, while barriers were mainly perceived on an organizational level.Keywords
This publication has 31 references indexed in Scilit:
- Decision aids that really promote shared decision making: the pace quickensBMJ, 2015
- Shared decision making in dermatology: asking patients, ‘What is important to you?’British Journal of Dermatology, 2014
- Knowledge is not power for patients: A systematic review and thematic synthesis of patient-reported barriers and facilitators to shared decision makingPatient Education and Counseling, 2014
- Assessments of the extent to which health‐care providers involve patients in decision making: a systematic review of studies using the OPTION instrumentHealth Expectations, 2013
- Shared Decision Making: A Model for Clinical PracticeJournal of General Internal Medicine, 2012
- Measurement of shared decision making – a review of instrumentsZeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 2011
- Barriers and facilitators to implementing shared decision-making in clinical practice: Update of a systematic review of health professionals’ perceptionsPatient Education and Counseling, 2008
- An integrative model of shared decision making in medical encountersPatient Education and Counseling, 2006
- Remembering what the doctor said: Organization and adults' memory for medical informationExperimental Aging Research, 1996
- Patient-Centered MedicineJAMA, 1996